Related Experiment Videos
Tetracycline administration restores osteoblast structure and function during experimental diabetes
T Sasaki1, H Kaneko, N S Ramamurthy
1Second Department of Oral Anatomy, School of Dentistry, Showa University, Tokyo, Japan.
The Anatomical Record
|September 1, 1991
Summary
Tetracyclines, including minocycline and CMT, improve osteoblast function and bone formation in diabetic rats. This study shows these drugs restore osteoblast structure and protein synthesis, preventing osteopenia.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Osteopenia is a known complication of diabetes mellitus in both humans and animals.
- Previous research indicated tetracyclines prevent osteopenia in diabetic rats by restoring osteoblast morphology.
Purpose of the Study:
- To investigate the functional effects of tetracyclines on osteoblasts in streptozotocin-induced diabetic rats.
- To assess the impact of minocycline (MC) and a non-antimicrobial tetracycline analog (CMT) on osteoblast activity and bone matrix formation.
Main Methods:
- Diabetic and non-diabetic rats were treated with minocycline (MC) or CMT.
- Ultracytochemical localization of alkaline phosphatase (ALPase) and Ca-ATPase activities was performed on humeri.
- 3H-proline incorporation and light microscopic autoradiography assessed procollagen synthesis and secretion; osteoid volume was morphometrically analyzed.
Main Results:
- Diabetes induced flattened bone-lining cells with reduced protein synthesis and transport organelles.
- MC and CMT treatment restored osteoblast structure, increasing 3H-proline incorporation and protein secretion.
- Tetracycline administration enhanced osteoid matrix formation in diabetic rats, similar to controls.
Conclusions:
- Tetracyclines, particularly CMT, effectively restore osteoblast function in diabetic rats.
- The findings suggest a therapeutic potential for tetracyclines in managing diabetes-related bone complications.